nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—Methazolamide—CYP2E1—liver cancer	0.0262	1	CrCbGaD
Acetazolamide—Hepatic function abnormal—Sorafenib—liver cancer	0.00863	0.0273	CcSEcCtD
Acetazolamide—Hepatic failure—Sorafenib—liver cancer	0.0084	0.0266	CcSEcCtD
Acetazolamide—Hyponatraemia—Sorafenib—liver cancer	0.00758	0.024	CcSEcCtD
Acetazolamide—AQP1—gall bladder—liver cancer	0.00702	0.291	CbGeAlD
Acetazolamide—Hypokalaemia—Sorafenib—liver cancer	0.00687	0.0217	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00679	0.0215	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00576	0.0182	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Sorafenib—liver cancer	0.0055	0.0174	CcSEcCtD
Acetazolamide—Erythema multiforme—Sorafenib—liver cancer	0.00494	0.0156	CcSEcCtD
Acetazolamide—CA9—gall bladder—liver cancer	0.00493	0.204	CbGeAlD
Acetazolamide—Tinnitus—Sorafenib—liver cancer	0.00487	0.0154	CcSEcCtD
Acetazolamide—Flushing—Sorafenib—liver cancer	0.00484	0.0153	CcSEcCtD
Acetazolamide—Glycosuria—Epirubicin—liver cancer	0.00474	0.015	CcSEcCtD
Acetazolamide—Injection site pain—Epirubicin—liver cancer	0.0047	0.0149	CcSEcCtD
Acetazolamide—Blood disorder—Epirubicin—liver cancer	0.0046	0.0146	CcSEcCtD
Acetazolamide—Dysgeusia—Sorafenib—liver cancer	0.00445	0.0141	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—liver cancer	0.00439	0.0139	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Epirubicin—liver cancer	0.00437	0.0138	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—liver cancer	0.00435	0.0138	CcSEcCtD
Acetazolamide—Blood disorder—Doxorubicin—liver cancer	0.00426	0.0135	CcSEcCtD
Acetazolamide—Leukopenia—Sorafenib—liver cancer	0.00407	0.0129	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—liver cancer	0.00405	0.0128	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—liver cancer	0.00375	0.0119	CcSEcCtD
Acetazolamide—Anaphylactic shock—Sorafenib—liver cancer	0.00371	0.0117	CcSEcCtD
Acetazolamide—Shock—Sorafenib—liver cancer	0.00365	0.0116	CcSEcCtD
Acetazolamide—Thrombocytopenia—Sorafenib—liver cancer	0.00363	0.0115	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—liver cancer	0.00361	0.0114	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—liver cancer	0.00347	0.011	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—liver cancer	0.00334	0.0106	CcSEcCtD
Acetazolamide—Dyspepsia—Sorafenib—liver cancer	0.00326	0.0103	CcSEcCtD
Acetazolamide—Decreased appetite—Sorafenib—liver cancer	0.00322	0.0102	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.0032	0.0101	CcSEcCtD
Acetazolamide—Fatigue—Sorafenib—liver cancer	0.0032	0.0101	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—liver cancer	0.00319	0.0101	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—liver cancer	0.00318	0.0101	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—liver cancer	0.0031	0.00982	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—liver cancer	0.00295	0.00935	CcSEcCtD
Acetazolamide—Urticaria—Sorafenib—liver cancer	0.00295	0.00933	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—liver cancer	0.00294	0.0093	CcSEcCtD
Acetazolamide—Body temperature increased—Sorafenib—liver cancer	0.00293	0.00928	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—liver cancer	0.00288	0.00912	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—liver cancer	0.00287	0.00909	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—liver cancer	0.00286	0.00905	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—liver cancer	0.0028	0.00886	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00267	0.00844	CcSEcCtD
Acetazolamide—Asthenia—Sorafenib—liver cancer	0.00266	0.00842	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—liver cancer	0.00264	0.00837	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—liver cancer	0.00262	0.0083	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—liver cancer	0.00259	0.0082	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—liver cancer	0.00254	0.00803	CcSEcCtD
Acetazolamide—Diarrhoea—Sorafenib—liver cancer	0.00254	0.00803	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00251	0.00795	CcSEcCtD
Acetazolamide—CA5A—liver—liver cancer	0.00247	0.102	CbGeAlD
Acetazolamide—Dizziness—Sorafenib—liver cancer	0.00245	0.00776	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—liver cancer	0.00243	0.00768	CcSEcCtD
Acetazolamide—Vomiting—Sorafenib—liver cancer	0.00236	0.00746	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—liver cancer	0.00235	0.00743	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00232	0.00736	CcSEcCtD
Acetazolamide—Headache—Sorafenib—liver cancer	0.00232	0.00735	CcSEcCtD
Acetazolamide—Nausea—Sorafenib—liver cancer	0.0022	0.00697	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—liver cancer	0.0022	0.00696	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—liver cancer	0.00215	0.0068	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00213	0.00674	CcSEcCtD
Acetazolamide—AQP1—liver—liver cancer	0.00206	0.0852	CbGeAlD
Acetazolamide—Haematuria—Epirubicin—liver cancer	0.00205	0.00649	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—liver cancer	0.00204	0.00644	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—liver cancer	0.00203	0.00643	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—liver cancer	0.00201	0.00635	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—liver cancer	0.00199	0.00629	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00197	0.00624	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—liver cancer	0.00192	0.00608	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—liver cancer	0.0019	0.006	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—liver cancer	0.00188	0.00595	CcSEcCtD
Acetazolamide—CA2—gall bladder—liver cancer	0.00187	0.0775	CbGeAlD
Acetazolamide—Agranulocytosis—Doxorubicin—liver cancer	0.00186	0.00587	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—liver cancer	0.00182	0.00577	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—liver cancer	0.0018	0.00569	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—liver cancer	0.00179	0.00567	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—liver cancer	0.00178	0.00562	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—liver cancer	0.00169	0.00534	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—liver cancer	0.00166	0.00527	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—liver cancer	0.00166	0.00524	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—liver cancer	0.00164	0.00521	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—liver cancer	0.00156	0.00493	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—liver cancer	0.00154	0.00489	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—liver cancer	0.00152	0.00482	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—liver cancer	0.00151	0.00479	CcSEcCtD
Acetazolamide—CA3—liver—liver cancer	0.00151	0.0625	CbGeAlD
Acetazolamide—Leukopenia—Epirubicin—liver cancer	0.0015	0.00476	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—liver cancer	0.00145	0.00461	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—liver cancer	0.00144	0.00456	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—liver cancer	0.00143	0.00452	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—liver cancer	0.00141	0.00447	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—liver cancer	0.0014	0.00444	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—liver cancer	0.00139	0.0044	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—liver cancer	0.00138	0.00437	CcSEcCtD
Acetazolamide—CA14—liver—liver cancer	0.00137	0.0567	CbGeAlD
Acetazolamide—Anaphylactic shock—Epirubicin—liver cancer	0.00137	0.00434	CcSEcCtD
Acetazolamide—Shock—Epirubicin—liver cancer	0.00135	0.00427	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—liver cancer	0.00135	0.00426	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—liver cancer	0.00134	0.00425	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—liver cancer	0.00131	0.00414	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—liver cancer	0.00128	0.00405	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—liver cancer	0.00127	0.00401	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—liver cancer	0.00125	0.00395	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—liver cancer	0.00124	0.00393	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—liver cancer	0.00123	0.0039	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—liver cancer	0.00122	0.00386	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—liver cancer	0.00121	0.00382	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—liver cancer	0.00119	0.00377	CcSEcCtD
Acetazolamide—CA2—embryo—liver cancer	0.00119	0.0491	CbGeAlD
Acetazolamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.00118	0.00375	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—liver cancer	0.00118	0.00374	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—liver cancer	0.00114	0.0036	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—liver cancer	0.00113	0.00358	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—liver cancer	0.00113	0.00357	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—liver cancer	0.00112	0.00353	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—liver cancer	0.0011	0.00349	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00109	0.00347	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—liver cancer	0.00109	0.00346	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—liver cancer	0.00109	0.00345	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—liver cancer	0.00108	0.00343	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—liver cancer	0.00104	0.00331	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—liver cancer	0.00101	0.00319	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—liver cancer	0.001	0.00317	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—liver cancer	0.000983	0.00311	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—liver cancer	0.000938	0.00297	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—liver cancer	0.00091	0.00288	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—liver cancer	0.000906	0.00287	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—liver cancer	0.000871	0.00276	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—liver cancer	0.000868	0.00275	CcSEcCtD
Acetazolamide—Headache—Epirubicin—liver cancer	0.000859	0.00272	CcSEcCtD
Acetazolamide—CA1—liver—liver cancer	0.000847	0.035	CbGeAlD
Acetazolamide—Dizziness—Doxorubicin—liver cancer	0.000839	0.00265	CcSEcCtD
Acetazolamide—Nausea—Epirubicin—liver cancer	0.000814	0.00258	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—liver cancer	0.000806	0.00255	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—liver cancer	0.000794	0.00252	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—liver cancer	0.000753	0.00238	CcSEcCtD
Acetazolamide—CA2—liver—liver cancer	0.000549	0.0227	CbGeAlD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000476	0.000751	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—JUN—liver cancer	0.000475	0.000749	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CRABP1—liver cancer	0.000474	0.000748	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.00047	0.000742	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYCS—liver cancer	0.000466	0.000735	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYCS—liver cancer	0.000466	0.000735	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTA1—liver cancer	0.000461	0.000727	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPARG—liver cancer	0.000461	0.000727	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP2E1—liver cancer	0.000461	0.000727	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1A—liver cancer	0.00046	0.000726	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GGT1—liver cancer	0.000457	0.000721	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GGT1—liver cancer	0.000457	0.000721	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GOT1—liver cancer	0.000457	0.000721	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GOT1—liver cancer	0.000457	0.000721	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NAT2—liver cancer	0.000456	0.000719	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000454	0.000716	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTP1—liver cancer	0.000451	0.000712	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HPGDS—liver cancer	0.000451	0.000711	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK8—liver cancer	0.000449	0.000709	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000449	0.000708	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HMOX1—liver cancer	0.000445	0.000702	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000443	0.000698	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTP1—liver cancer	0.00044	0.000693	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTP1—liver cancer	0.00044	0.000693	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALDOB—liver cancer	0.000437	0.000689	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HMOX1—liver cancer	0.000433	0.000684	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HMOX1—liver cancer	0.000433	0.000684	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HPGDS—liver cancer	0.000432	0.000682	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYCS—liver cancer	0.000431	0.00068	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GGT1—liver cancer	0.000423	0.000668	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GOT1—liver cancer	0.000423	0.000668	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CB—liver cancer	0.000422	0.000666	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CD—liver cancer	0.00042	0.000662	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CRABP1—liver cancer	0.000417	0.000658	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—liver cancer	0.000415	0.000655	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HPGDS—liver cancer	0.000414	0.000654	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ALB—liver cancer	0.000414	0.000654	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTM1—liver cancer	0.000414	0.000654	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—STAT3—liver cancer	0.000411	0.000648	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTP1—liver cancer	0.00041	0.000647	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTP1—liver cancer	0.00041	0.000647	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HMOX1—liver cancer	0.000405	0.000639	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HMOX1—liver cancer	0.000405	0.000639	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTM1—liver cancer	0.000404	0.000637	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTM1—liver cancer	0.000404	0.000637	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PSMD10—liver cancer	0.000402	0.000634	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PSMA4—liver cancer	0.000402	0.000634	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000395	0.000624	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1A1—liver cancer	0.000393	0.00062	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GOT2—liver cancer	0.000391	0.000617	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PSMA4—liver cancer	0.000385	0.000608	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PSMD10—liver cancer	0.000385	0.000608	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1A1—liver cancer	0.000383	0.000604	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1A1—liver cancer	0.000383	0.000604	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTP1—liver cancer	0.00038	0.0006	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTM1—liver cancer	0.000377	0.000595	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTM1—liver cancer	0.000377	0.000595	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000376	0.000594	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HMOX1—liver cancer	0.000375	0.000592	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GOT2—liver cancer	0.000375	0.000591	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PSMD10—liver cancer	0.000369	0.000583	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PSMA4—liver cancer	0.000369	0.000583	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP2E1—liver cancer	0.000368	0.00058	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—liver cancer	0.000366	0.000578	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CB—liver cancer	0.000366	0.000577	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000366	0.000577	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HPGDS—liver cancer	0.000364	0.000575	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GOT2—liver cancer	0.000359	0.000567	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARA—liver cancer	0.000359	0.000567	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000359	0.000566	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1A1—liver cancer	0.000357	0.000564	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1A1—liver cancer	0.000357	0.000564	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—liver cancer	0.000357	0.000563	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—liver cancer	0.000357	0.000563	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000356	0.000562	CbGpPWpGaD
Acetazolamide—CYP3A4—liver—liver cancer	0.000354	0.0147	CbGeAlD
Acetazolamide—CA2—Metabolism—CYP2E1—liver cancer	0.000352	0.000556	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARA—liver cancer	0.00035	0.000553	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARA—liver cancer	0.00035	0.000553	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTM1—liver cancer	0.000349	0.000551	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYCS—liver cancer	0.000344	0.000543	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP2E1—liver cancer	0.000338	0.000533	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GGT1—liver cancer	0.000337	0.000532	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GOT1—liver cancer	0.000337	0.000532	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—liver cancer	0.000333	0.000526	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—liver cancer	0.000333	0.000526	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1A1—liver cancer	0.000331	0.000523	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYCS—liver cancer	0.00033	0.00052	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARA—liver cancer	0.000327	0.000516	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARA—liver cancer	0.000327	0.000516	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PSMD10—liver cancer	0.000325	0.000512	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PSMA4—liver cancer	0.000325	0.000512	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GGT1—liver cancer	0.000324	0.000511	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GOT1—liver cancer	0.000324	0.000511	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYCS—liver cancer	0.000316	0.000499	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GOT2—liver cancer	0.000316	0.000498	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—liver cancer	0.000314	0.000495	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GGT1—liver cancer	0.00031	0.000489	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GOT1—liver cancer	0.00031	0.000489	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000309	0.000488	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—liver cancer	0.000309	0.000487	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CG—liver cancer	0.000308	0.000486	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTP1—liver cancer	0.000303	0.000478	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARA—liver cancer	0.000303	0.000478	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CG—liver cancer	0.0003	0.000473	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CG—liver cancer	0.0003	0.000473	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—liver cancer	0.000299	0.000472	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP2E1—liver cancer	0.000297	0.000469	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—liver cancer	0.000297	0.000469	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000292	0.000461	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTP1—liver cancer	0.000291	0.000459	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—liver cancer	0.000289	0.000457	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—liver cancer	0.000289	0.000457	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000288	0.000455	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—liver cancer	0.000287	0.000453	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—liver cancer	0.000287	0.000452	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CG—liver cancer	0.00028	0.000442	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CG—liver cancer	0.00028	0.000442	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTP1—liver cancer	0.000279	0.00044	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—liver cancer	0.000279	0.00044	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYCS—liver cancer	0.000278	0.000438	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—liver cancer	0.000275	0.000434	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GOT1—liver cancer	0.000273	0.00043	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GGT1—liver cancer	0.000273	0.00043	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CD—liver cancer	0.000271	0.000427	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—liver cancer	0.00027	0.000426	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—liver cancer	0.00027	0.000426	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000268	0.000424	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—liver cancer	0.000267	0.000421	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—liver cancer	0.000267	0.000421	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A1—liver cancer	0.000264	0.000417	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CD—liver cancer	0.000264	0.000416	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CD—liver cancer	0.000264	0.000416	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—liver cancer	0.00026	0.000411	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—liver cancer	0.00026	0.000411	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CG—liver cancer	0.000259	0.000409	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—liver cancer	0.000257	0.000406	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—liver cancer	0.000256	0.000404	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A1—liver cancer	0.000253	0.000399	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—liver cancer	0.00025	0.000395	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.00025	0.000394	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—liver cancer	0.000246	0.000388	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CD—liver cancer	0.000246	0.000388	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CD—liver cancer	0.000246	0.000388	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—liver cancer	0.000245	0.000387	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—liver cancer	0.000243	0.000383	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—liver cancer	0.000243	0.000383	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A1—liver cancer	0.000243	0.000383	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—liver cancer	0.000242	0.000381	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARA—liver cancer	0.000242	0.000381	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000241	0.00038	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000238	0.000375	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—liver cancer	0.000236	0.000372	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CB—liver cancer	0.000236	0.000372	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARA—liver cancer	0.000232	0.000365	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CB—liver cancer	0.00023	0.000363	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CB—liver cancer	0.00023	0.000363	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CD—liver cancer	0.000228	0.00036	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—liver cancer	0.000226	0.000357	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—liver cancer	0.000225	0.000355	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—liver cancer	0.000225	0.000355	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—liver cancer	0.000223	0.000352	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARA—liver cancer	0.000222	0.00035	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000222	0.00035	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000219	0.000345	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CB—liver cancer	0.000215	0.000339	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CB—liver cancer	0.000215	0.000339	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A1—liver cancer	0.000213	0.000337	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—liver cancer	0.00021	0.000332	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.00021	0.000331	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000207	0.000327	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CG—liver cancer	0.000207	0.000326	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—liver cancer	0.0002	0.000315	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—liver cancer	0.000199	0.000314	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CB—liver cancer	0.000199	0.000314	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CG—liver cancer	0.000198	0.000313	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARA—liver cancer	0.000195	0.000308	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—liver cancer	0.000191	0.000302	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CG—liver cancer	0.00019	0.0003	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	0.000186	0.000293	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—liver cancer	0.000184	0.00029	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—liver cancer	0.000182	0.000288	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CD—liver cancer	0.000182	0.000287	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—liver cancer	0.00018	0.000283	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CD—liver cancer	0.000174	0.000275	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—liver cancer	0.000172	0.000272	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000168	0.000265	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CG—liver cancer	0.000167	0.000264	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CD—liver cancer	0.000167	0.000264	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—liver cancer	0.000165	0.00026	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—liver cancer	0.000161	0.000255	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CB—liver cancer	0.000159	0.00025	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UGDH—liver cancer	0.000157	0.000248	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CB—liver cancer	0.000152	0.00024	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EPT1—liver cancer	0.000148	0.000233	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CD—liver cancer	0.000147	0.000232	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CB—liver cancer	0.000146	0.00023	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—liver cancer	0.000145	0.000229	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—liver cancer	0.000144	0.000227	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—liver cancer	0.00014	0.000221	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—liver cancer	0.00014	0.000221	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TAT—liver cancer	0.00014	0.000221	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—liver cancer	0.000131	0.000206	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—liver cancer	0.000131	0.000206	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CB—liver cancer	0.000128	0.000202	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—liver cancer	0.000121	0.000191	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—liver cancer	0.000117	0.000185	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—liver cancer	0.000114	0.000181	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—liver cancer	0.000114	0.000181	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—liver cancer	0.000107	0.000169	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—liver cancer	0.000107	0.000169	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—liver cancer	9.9e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—liver cancer	9.66e-05	0.000152	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLUL—liver cancer	9.52e-05	0.00015	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CPT1B—liver cancer	9.52e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—liver cancer	9.26e-05	0.000146	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NR1H4—liver cancer	9.18e-05	0.000145	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA3—liver cancer	9.02e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—liver cancer	8.88e-05	0.00014	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA4—liver cancer	8.25e-05	0.00013	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA2—liver cancer	8.04e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—liver cancer	7.89e-05	0.000125	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—liver cancer	7.81e-05	0.000123	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA1—liver cancer	7.76e-05	0.000122	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAT2—liver cancer	7.67e-05	0.000121	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—liver cancer	7.57e-05	0.000119	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDOB—liver cancer	7.36e-05	0.000116	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—liver cancer	7.26e-05	0.000114	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CRABP1—liver cancer	7.02e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—liver cancer	6.38e-05	0.000101	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HPGDS—liver cancer	6.13e-05	9.68e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSMA4—liver cancer	5.47e-05	8.63e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSMD10—liver cancer	5.47e-05	8.63e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GOT2—liver cancer	5.32e-05	8.39e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2E1—liver cancer	5e-05	7.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYCS—liver cancer	4.68e-05	7.38e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GOT1—liver cancer	4.59e-05	7.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GGT1—liver cancer	4.59e-05	7.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—liver cancer	4.12e-05	6.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—liver cancer	4.07e-05	6.42e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—liver cancer	3.79e-05	5.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A1—liver cancer	3.59e-05	5.67e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—liver cancer	3.35e-05	5.28e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARA—liver cancer	3.29e-05	5.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.81e-05	4.44e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—liver cancer	2.72e-05	4.29e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CD—liver cancer	2.47e-05	3.9e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—liver cancer	2.44e-05	3.85e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CB—liver cancer	2.16e-05	3.4e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.31e-05	2.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—liver cancer	1.07e-05	1.69e-05	CbGpPWpGaD
